A researcher at the IU Indianapolis Fairbanks School of Public Health has identified a set of novel biomarkers that could significantly improve early detection of pancreatic cancer, a disease with a ...
Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces challenges in uptake and education. Multistakeholder partnerships and ...
BERKELEY, Calif. and MAINZ, Germany, June 10, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the ...
SEATTLE — July 1, 2025 — Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. Founded in 1975, the Oral Medicine Service at Fred Hutch was the ...
UC Davis teams are using Fitbits, blood tests and air sampling to study why firefighters face high cancer risk.
A sponge-like gold nanoparticle platform could deliver faster, more accurate, and less invasive ovarian cancer diagnostics.
Recreational physical activity or lack thereof could be a factor in whether teenage girls develop breast cancer later.
Mainz Biomed’s product candidate portfolio also includes PancAlert, an early-stage pancreatic cancer screening test based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback